MIDAZOLAM

MIDAZOLAM was reported 27286 times

These side effects are most commonly reported by patients taking MIDAZOLAM:

# Side effect Count
0 DRUG INEFFECTIVE 3208
1 OFF LABEL USE 2487
2 SEIZURE 1639
3 HYPOTENSION 1399
4 DRUG INTERACTION 1152
5 ACUTE KIDNEY INJURY 895
6 TOXICITY TO VARIOUS AGENTS 881
7 PYREXIA 858
8 CARDIAC ARREST 853
9 DEATH 720
10 STATUS EPILEPTICUS 670
11 CONDITION AGGRAVATED 655
12 RESPIRATORY FAILURE 638
13 TACHYCARDIA 618
14 PRODUCT USE IN UNAPPROVED INDICATION 616
15 NAUSEA 608
16 DYSPNOEA 596
17 ANAPHYLACTIC REACTION 584
18 PNEUMONIA 575
19 OVERDOSE 557
20 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 556
21 PAIN 555
22 AGITATION 554
23 VOMITING 549
24 SOMNOLENCE 543
25 ANAEMIA 542
26 BRADYCARDIA 530
27 DIARRHOEA 517
28 HYPOXIA 470
29 SEROTONIN SYNDROME 464
30 RENAL FAILURE 463
31 ANXIETY 443
32 ABDOMINAL PAIN 442
33 THROMBOCYTOPENIA 438
34 RHABDOMYOLYSIS 432
35 OXYGEN SATURATION DECREASED 419
36 HEADACHE 410
37 METABOLIC ACIDOSIS 407
38 FATIGUE 406
39 MULTIPLE ORGAN DYSFUNCTION SYNDROME 402
40 HYPERTENSION 394
41 RASH 387
42 SEPSIS 383
43 CONSTIPATION 381
44 WEIGHT DECREASED 378
45 GENERALISED TONIC-CLONIC SEIZURE 376
46 ERYTHEMA 367
47 DELIRIUM 358
48 COMA 355
49 MALAISE 348
50 CONFUSIONAL STATE 345
51 LOSS OF CONSCIOUSNESS 320
52 DEPRESSED LEVEL OF CONSCIOUSNESS 309
53 INSOMNIA 304
54 SEPTIC SHOCK 299
55 RENAL IMPAIRMENT 296
56 ASTHENIA 295
57 MULTIPLE-DRUG RESISTANCE 294
58 PRODUCT USE ISSUE 287
59 DECREASED APPETITE 286
60 MATERNAL EXPOSURE DURING PREGNANCY 285
61 UNRESPONSIVE TO STIMULI 285
62 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 279
63 DRUG ABUSE 278
64 NO ADVERSE EVENT 275
65 RESPIRATORY DEPRESSION 274
66 ANAPHYLACTIC SHOCK 269
67 DIZZINESS 269
68 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 269
69 COLITIS 265
70 FOETAL EXPOSURE DURING PREGNANCY 260
71 FALL 255
72 CARDIO-RESPIRATORY ARREST 254
73 MYOCLONUS 243
74 ELECTROCARDIOGRAM QT PROLONGED 241
75 EPILEPSY 238
76 GENERAL PHYSICAL HEALTH DETERIORATION 234
77 HYPOKALAEMIA 229
78 URINARY TRACT INFECTION 229
79 DEPRESSION 226
80 ALANINE AMINOTRANSFERASE INCREASED 222
81 TREMOR 221
82 INTENTIONAL OVERDOSE 220
83 ENCEPHALOPATHY 218
84 ACUTE RESPIRATORY DISTRESS SYNDROME 215
85 COUGH 215
86 ATRIAL FIBRILLATION 212
87 SHOCK 212
88 ARTHRALGIA 211
89 BLOOD PRESSURE DECREASED 211
90 CARDIAC FAILURE 208
91 COLITIS ULCERATIVE 205
92 DRUG HYPERSENSITIVITY 205
93 THERAPY NON-RESPONDER 201
94 PULMONARY OEDEMA 197
95 RESPIRATORY ARREST 197
96 AGGRESSION 196
97 URTICARIA 196
98 CIRCULATORY COLLAPSE 195
99 RECTAL HAEMORRHAGE 195
100 FEBRILE NEUTROPENIA 194
101 NEUTROPENIA 191
102 FREQUENT BOWEL MOVEMENTS 190
103 BRAIN OEDEMA 189
104 HAEMATOCHEZIA 187
105 ARRHYTHMIA 182
106 PRODUCT DOSE OMISSION ISSUE 181
107 PRURITUS 181
108 HAEMODYNAMIC INSTABILITY 179
109 SEDATION 179
110 COGNITIVE DISORDER 178
111 TREATMENT FAILURE 178
112 BLOOD CREATINE PHOSPHOKINASE INCREASED 177
113 EXPOSURE DURING PREGNANCY 177
114 GAIT DISTURBANCE 176
115 LACTIC ACIDOSIS 174
116 HYPERKALAEMIA 173
117 PLEURAL EFFUSION 173
118 ALTERED STATE OF CONSCIOUSNESS 172
119 HYPERHIDROSIS 172
120 HYPERSENSITIVITY 171
121 RESPIRATORY DISTRESS 170
122 BLOOD CREATININE INCREASED 169
123 DISEASE PROGRESSION 168
124 CHRONIC KIDNEY DISEASE 166
125 MEMORY IMPAIRMENT 166
126 PARTIAL SEIZURES 166
127 ORAL CANDIDIASIS 165
128 ABDOMINAL DISTENSION 164
129 HALLUCINATION 164
130 HEART RATE INCREASED 164
131 HEPATIC FAILURE 164
132 HYPONATRAEMIA 163
133 PNEUMONIA ASPIRATION 163
134 CHEST PAIN 162
135 PREMATURE BABY 162
136 SUICIDE ATTEMPT 160
137 DYSKINESIA 159
138 ASPARTATE AMINOTRANSFERASE INCREASED 157
139 INJURY 156
140 ACUTE RESPIRATORY FAILURE 155
141 PROPOFOL INFUSION SYNDROME 154
142 INFUSION RELATED REACTION 152
143 RESPIRATORY ACIDOSIS 152
144 COMPLETED SUICIDE 151
145 PROCTITIS 150
146 INTENTIONAL PRODUCT MISUSE 149
147 CARDIOGENIC SHOCK 148
148 EMOTIONAL DISTRESS 147
149 BRONCHOSPASM 146
150 VENTRICULAR TACHYCARDIA 146
151 INFECTION 144
152 HAEMORRHAGE 143
153 CHRONIC SINUSITIS 141
154 FEMALE GENITAL TRACT FISTULA 141
155 BLOOD PRESSURE INCREASED 140
156 DRUG RESISTANCE 140
157 NEUROLEPTIC MALIGNANT SYNDROME 140
158 APNOEA 137
159 DISSEMINATED INTRAVASCULAR COAGULATION 137
160 DYSPEPSIA 137
161 RADICULOPATHY 137
162 TOXIC EPIDERMAL NECROLYSIS 137
163 PLATELET COUNT DECREASED 136
164 COVID-19 134
165 DRUG DEPENDENCE 134
166 HYPERTHERMIA MALIGNANT 134
167 PULMONARY EMBOLISM 134
168 TACHYPNOEA 134
169 BACK PAIN 133
170 CHOLESTASIS 133
171 OEDEMA PERIPHERAL 132
172 GASTROINTESTINAL HAEMORRHAGE 131
173 MUSCLE RIGIDITY 131
174 RESTLESSNESS 131
175 FEAR 130
176 VAGINAL FLATULENCE 130
177 DRUG WITHDRAWAL SYNDROME 129
178 HYPERTHERMIA 129
179 INTENTIONAL PRODUCT USE ISSUE 129
180 COAGULOPATHY 128
181 MALIGNANT NEOPLASM PROGRESSION 128
182 VAGINAL DISCHARGE 128
183 MACULAR DEGENERATION 127
184 RENAL FAILURE ACUTE 127
185 WEIGHT INCREASED 127
186 PARAESTHESIA ORAL 126
187 RENAL INJURY 125
188 URINARY RETENTION 125
189 CHILLS 124
190 DYSPHAGIA 124
191 MULTI-ORGAN FAILURE 124
192 PULSELESS ELECTRICAL ACTIVITY 122
193 DEHYDRATION 121
194 MYDRIASIS 121
195 DIABETES INSIPIDUS 120
196 DRUG-INDUCED LIVER INJURY 120
197 PARADOXICAL DRUG REACTION 119
198 DEEP VEIN THROMBOSIS 118
199 PROCEDURAL PAIN 118
200 LEUKOCYTOSIS 117
201 STRESS 117
202 VENTRICULAR FIBRILLATION 117
203 ACIDOSIS 116
204 MENTAL STATUS CHANGES 116
205 AMNESIA 115
206 HEPATIC FUNCTION ABNORMAL 114
207 PANCYTOPENIA 114
208 HAEMOGLOBIN DECREASED 113
209 PAIN IN EXTREMITY 113
210 HEPATOCELLULAR INJURY 112
211 RASH MACULO-PAPULAR 110
212 SINUS TACHYCARDIA 110
213 CEREBROVASCULAR ACCIDENT 108
214 HEPATIC ENZYME INCREASED 108
215 NEUROPATHY PERIPHERAL 108
216 SEDATION COMPLICATION 108
217 WITHDRAWAL SYNDROME 108
218 LETHARGY 107
219 MUSCLE SPASMS 107
220 ANGIOEDEMA 106
221 DISORIENTATION 106
222 IRRITABILITY 106
223 UNEVALUABLE EVENT 106
224 APHASIA 105
225 DYSTONIA 104
226 HOSPITALISATION 104
227 INTESTINAL ISCHAEMIA 104
228 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 104
229 MUSCULAR WEAKNESS 103
230 NERVOUS SYSTEM DISORDER 103
231 ABDOMINAL PAIN UPPER 102
232 CYANOSIS 102
233 SUICIDAL IDEATION 100
234 HEART RATE DECREASED 99
235 INFLAMMATION 99
236 SYNCOPE 99
237 ANAESTHETIC COMPLICATION NEUROLOGICAL 98
238 PNEUMOTHORAX 98
239 PSYCHOTIC DISORDER 98
240 RESPIRATORY DISORDER 97
241 ACUTE HEPATIC FAILURE 96
242 DRUG LEVEL INCREASED 96
243 HAEMATEMESIS 96
244 HYPOAESTHESIA 96
245 PREMATURE DELIVERY 96
246 SPEECH DISORDER 96
247 DRUG INTOLERANCE 95
248 SINUS BRADYCARDIA 95
249 ANHEDONIA 94
250 STRESS CARDIOMYOPATHY 94
251 THERAPY INTERRUPTED 94
252 BALANCE DISORDER 93
253 DISTURBANCE IN ATTENTION 93
254 BLOOD LACTIC ACID INCREASED 92
255 ELECTROENCEPHALOGRAM ABNORMAL 92
256 HYPOTONIA 92
257 TRANSAMINASES INCREASED 91
258 INCORRECT DOSE ADMINISTERED 90
259 CEREBRAL HAEMORRHAGE 89
260 DYSARTHRIA 89
261 PARAESTHESIA 88
262 VISUAL IMPAIRMENT 88
263 NEUROTOXICITY 87
264 BLOOD BILIRUBIN INCREASED 86
265 EOSINOPHILIA 86
266 MYOCARDIAL INFARCTION 85
267 PSYCHOMOTOR HYPERACTIVITY 85
268 TOXIC ENCEPHALOPATHY 85
269 ABNORMAL BEHAVIOUR 83
270 CYTOKINE RELEASE SYNDROME 83
271 HEPATITIS 83
272 HYPOGLYCAEMIA 83
273 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 83
274 PRODUCT QUALITY ISSUE 83
275 PULMONARY HYPERTENSION 82
276 VENTRICULAR EXTRASYSTOLES 82
277 WHITE BLOOD CELL COUNT INCREASED 82
278 ACUTE MYOCARDIAL INFARCTION 81
279 HEPATIC CYTOLYSIS 81
280 HYPERCAPNIA 81
281 HYPOVENTILATION 81
282 LEUKOPENIA 81
283 EPISTAXIS 80
284 HYPERAMMONAEMIA 80
285 HYPERGLYCAEMIA 80
286 CONVULSION 79
287 UPPER RESPIRATORY TRACT INFECTION 79
288 ANURIA 78
289 FEELING ABNORMAL 77
290 GASTROINTESTINAL DISORDER 77
291 INTERSTITIAL LUNG DISEASE 77
292 MUSCULOSKELETAL STIFFNESS 77
293 PALLOR 77
294 PNEUMONITIS 77
295 CATATONIA 75
296 HYPOTHYROIDISM 75
297 PRODUCT AVAILABILITY ISSUE 75
298 BLOOD GLUCOSE INCREASED 74
299 C-REACTIVE PROTEIN INCREASED 74
300 HAEMATURIA 74
301 HYPERNATRAEMIA 74
302 HYPOCALCAEMIA 74
303 MYALGIA 74
304 WHITE BLOOD CELL COUNT DECREASED 74
305 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 74
306 FLUSHING 73
307 ILEUS 73
308 COVID-19 PNEUMONIA 72
309 STEVENS-JOHNSON SYNDROME 72
310 SUPRAVENTRICULAR TACHYCARDIA 72
311 TINNITUS 72
312 SEIZURE CLUSTER 71
313 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 71
314 JAUNDICE 70
315 BACTERAEMIA 69
316 EXTRAPYRAMIDAL DISORDER 69
317 OEDEMA 69
318 TORSADE DE POINTES 69
319 ASCITES 68
320 DYSURIA 68
321 GAMMA-GLUTAMYLTRANSFERASE INCREASED 68
322 HYPERBILIRUBINAEMIA 68
323 KOUNIS SYNDROME 68
324 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 68
325 MYOCARDIAL ISCHAEMIA 68
326 OROPHARYNGEAL PAIN 68
327 ACCIDENTAL OVERDOSE 67
328 PANCREATITIS 67
329 ASPIRATION 66
330 ATELECTASIS 66
331 BLOOD ALKALINE PHOSPHATASE INCREASED 66
332 DELAYED RECOVERY FROM ANAESTHESIA 66
333 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 66
334 SHOCK HAEMORRHAGIC 66
335 TREATMENT NONCOMPLIANCE 66
336 AUTONOMIC NERVOUS SYSTEM IMBALANCE 65
337 VISION BLURRED 65
338 ANAESTHETIC COMPLICATION 64
339 ATAXIA 64
340 LIVER INJURY 64
341 BEHAVIOUR DISORDER 63
342 HYPOMAGNESAEMIA 63
343 HYPOTHERMIA 63
344 INFLUENZA 63
345 MOBILITY DECREASED 63
346 MOVEMENT DISORDER 63
347 BLOOD LACTATE DEHYDROGENASE INCREASED 62
348 CHEST DISCOMFORT 62
349 HYPERTRANSAMINASAEMIA 62
350 MEDICATION ERROR 62
351 NEPHROGENIC ANAEMIA 62
352 POISONING 62
353 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 61
354 NASOPHARYNGITIS 61
355 STAPHYLOCOCCAL INFECTION 61
356 BLOOD UREA INCREASED 60
357 BRAIN INJURY 60
358 DEPRESSED MOOD 60
359 DISEASE RECURRENCE 60
360 ILLNESS 60
361 KLEBSIELLA INFECTION 60
362 BRAIN DEATH 59
363 CROHN^S DISEASE 59
364 RASH ERYTHEMATOUS 59
365 TROPONIN INCREASED 59
366 ABSCESS 58
367 ELECTROLYTE IMBALANCE 58
368 MIOSIS 58
369 MUSCLE TWITCHING 58
370 OLIGURIA 58
371 PETIT MAL EPILEPSY 58
372 STOMATITIS 58
373 SWELLING FACE 58
374 HAEMORRHOIDS 57
375 HALLUCINATION, VISUAL 57
376 HYPERAESTHESIA 57
377 LOWER RESPIRATORY TRACT INFECTION 57
378 MOOD SWINGS 57
379 BLOOD POTASSIUM INCREASED 56
380 CARDIOMEGALY 56
381 CELLULITIS 56
382 HYPOPHAGIA 56
383 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 56
384 LIP SWELLING 56
385 PARALYSIS 56
386 POLYURIA 56
387 PULMONARY CONGESTION 56
388 THROMBOTIC MICROANGIOPATHY 56
389 CORONARY ARTERY DISEASE 55
390 EJECTION FRACTION DECREASED 55
391 END STAGE RENAL DISEASE 55
392 JOINT SWELLING 55
393 POST PROCEDURAL COMPLICATION 55
394 URINARY INCONTINENCE 55
395 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 54
396 MITRAL VALVE INCOMPETENCE 54
397 NYSTAGMUS 54
398 OSTEOARTHRITIS 54
399 PSEUDOMONAS INFECTION 54
400 UPPER GASTROINTESTINAL HAEMORRHAGE 54
401 WHEEZING 54
402 ENDOTRACHEAL INTUBATION 53
403 LEFT VENTRICULAR HYPERTROPHY 53
404 LUNG DISORDER 53
405 MYOCLONIC EPILEPSY 53
406 PALPITATIONS 53
407 CARDIAC FAILURE CONGESTIVE 52
408 HAEMOPTYSIS 52
409 INTERNATIONAL NORMALISED RATIO INCREASED 52
410 CONTUSION 51
411 DISCOMFORT 51
412 GASTROOESOPHAGEAL REFLUX DISEASE 51
413 LIVER FUNCTION TEST INCREASED 51
414 TUBULOINTERSTITIAL NEPHRITIS 51
415 ALOPECIA 50
416 BODY TEMPERATURE INCREASED 50
417 CLONUS 50
418 LIVER DISORDER 50
419 NEUTROPHIL COUNT DECREASED 50
420 PERIPHERAL SWELLING 50
421 ATRIOVENTRICULAR BLOCK 49
422 CARDIOTOXICITY 49
423 DYSPHONIA 49
424 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49
425 LYMPHADENOPATHY 49
426 PANIC ATTACK 49
427 ABDOMINAL DISCOMFORT 48
428 DRUG LEVEL BELOW THERAPEUTIC 48
429 HYPOVOLAEMIA 48
430 LEFT VENTRICULAR DYSFUNCTION 48
431 MUCOSAL INFLAMMATION 48
432 NEPHROLITHIASIS 48
433 PRODUCTIVE COUGH 48
434 ANAL INCONTINENCE 47
435 HEMIPARESIS 47
436 INJECTION SITE PAIN 47
437 INTRACRANIAL PRESSURE INCREASED 47
438 LOW BIRTH WEIGHT BABY 47
439 MENTAL DISORDER 47
440 OBSTRUCTIVE AIRWAYS DISORDER 47
441 PROCEDURAL COMPLICATION 47
442 PULSE ABSENT 47
443 UPPER AIRWAY OBSTRUCTION 47
444 ASTHMA 46
445 DRY MOUTH 46
446 ENCEPHALITIS 46
447 LIVER FUNCTION TEST ABNORMAL 46
448 MELAENA 46
449 RESPIRATORY TRACT INFECTION 46
450 SWELLING 46
451 THERAPEUTIC PRODUCT EFFECT DECREASED 46
452 ACUTE CORONARY SYNDROME 45
453 ADVERSE DRUG REACTION 45
454 ELECTROCARDIOGRAM ABNORMAL 45
455 HAEMATOMA 45
456 HEPATOTOXICITY 45
457 INTESTINAL PERFORATION 45
458 LUNG INFILTRATION 45
459 NECROSIS ISCHAEMIC 45
460 TRICUSPID VALVE INCOMPETENCE 45
461 URINE OUTPUT DECREASED 45
462 VENTRICULAR ARRHYTHMIA 45
463 ANTICHOLINERGIC SYNDROME 44
464 LABILE BLOOD PRESSURE 44
465 LONG QT SYNDROME 44
466 PANCREATITIS ACUTE 44
467 POST PROCEDURAL HAEMORRHAGE 44
468 PULMONARY ALVEOLAR HAEMORRHAGE 44
469 SWOLLEN TONGUE 44
470 TOXIC SKIN ERUPTION 44
471 WRONG PRODUCT ADMINISTERED 44
472 POISONING DELIBERATE 43
473 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 43
474 PULMONARY HAEMORRHAGE 43
475 SLEEP DISORDER 43
476 TONIC CONVULSION 43
477 DIABETES MELLITUS 42
478 DRUG DIVERSION 42
479 DRUG EFFECT DECREASED 42
480 EMOTIONAL DISORDER 42
481 ENCEPHALITIS AUTOIMMUNE 42
482 FEELING HOT 42
483 GASTRITIS 42
484 HEAD INJURY 42
485 LARYNGOSPASM 42
486 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 42
487 MENTAL IMPAIRMENT 42
488 METHAEMOGLOBINAEMIA 42
489 MIGRAINE 42
490 PERICARDIAL EFFUSION 42
491 CEREBRAL INFARCTION 41
492 HYPERCALCAEMIA 41
493 PRESCRIBED OVERDOSE 41
494 RASH PRURITIC 41
495 CATARACT 40
496 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40
497 CLOSTRIDIUM DIFFICILE COLITIS 40
498 COORDINATION ABNORMAL 40
499 DEVICE RELATED INFECTION 40
500 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 40
501 FLATULENCE 40
502 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 40
503 INCORRECT ROUTE OF DRUG ADMINISTRATION 40
504 RASH GENERALISED 40
505 REBOUND EFFECT 40
506 RESPIRATORY RATE INCREASED 40
507 ACUTE PULMONARY OEDEMA 39
508 AMYLASE INCREASED 39
509 BLOOD CALCIUM DECREASED 39
510 BRAIN HERNIATION 39
511 CONTRAINDICATED PRODUCT ADMINISTERED 39
512 DERMATITIS BULLOUS 39
513 DRUG EFFECT INCOMPLETE 39
514 DRUG LEVEL DECREASED 39
515 HYPERAMMONAEMIC ENCEPHALOPATHY 39
516 HYPERTRIGLYCERIDAEMIA 39
517 HYPOALBUMINAEMIA 39
518 METASTASES TO CENTRAL NERVOUS SYSTEM 39
519 MIXED LIVER INJURY 39
520 NECK PAIN 39
521 OXYGEN SATURATION ABNORMAL 39
522 PNEUMOCYSTIS JIROVECII PNEUMONIA 39
523 SINUSITIS 39
524 STRIDOR 39
525 THERAPEUTIC RESPONSE DECREASED 39
526 TONIC CLONIC MOVEMENTS 39
527 BLISTER 38
528 BRADYPNOEA 38
529 DEMENTIA 38
530 DRUG ERUPTION 38
531 DRUG USE DISORDER 38
532 GASTROENTERITIS 38
533 HYPERTONIA 38
534 NEUTROPHIL COUNT INCREASED 38
535 PATENT DUCTUS ARTERIOSUS 38
536 RENAL TUBULAR NECROSIS 38
537 ULCER 38
538 VASOPLEGIA SYNDROME 38
539 BLOOD MAGNESIUM DECREASED 37
540 DRUG WITHDRAWAL SYNDROME NEONATAL 37
541 FUNGAL INFECTION 37
542 HEPATITIS ACUTE 37
543 PROCEDURAL HYPOTENSION 37
544 UNWANTED AWARENESS DURING ANAESTHESIA 37
545 VENTRICULAR HYPOKINESIA 37
546 DEVICE ISSUE 36
547 IRON DEFICIENCY 36
548 MITOCHONDRIAL DNA MUTATION 36
549 NEUROMUSCULAR BLOCK PROLONGED 36
550 STUPOR 36
551 AGRANULOCYTOSIS 35
552 DRY SKIN 35
553 NEW ONSET REFRACTORY STATUS EPILEPTICUS 35
554 OSTEOPENIA 35
555 PNEUMONIA FUNGAL 35
556 RIGHT VENTRICULAR FAILURE 35
557 SUBDURAL HAEMATOMA 35
558 ACUTE MYELOID LEUKAEMIA 34
559 ADVERSE EVENT 34
560 ARTERIOSPASM CORONARY 34
561 CARDIAC DISORDER 34
562 CEREBRAL ATROPHY 34
563 CLOSTRIDIUM DIFFICILE INFECTION 34
564 EMPHYSEMA 34
565 FACIAL PARALYSIS 34
566 GRAND MAL CONVULSION 34
567 METASTASES TO LUNG 34
568 PNEUMONIA BACTERIAL 34
569 PULMONARY FIBROSIS 34
570 SUBARACHNOID HAEMORRHAGE 34
571 ANAPHYLACTOID REACTION 33
572 CARDIOVASCULAR INSUFFICIENCY 33
573 COLITIS ISCHAEMIC 33
574 CRYING 33
575 DIVERTICULITIS 33
576 GENE MUTATION 33
577 HYPERREFLEXIA 33
578 HYPOKINESIA 33
579 NOCTURIA 33
580 RESPIRATORY RATE DECREASED 33
581 UNDERDOSE 33
582 CHROMATURIA 32
583 FOETAL GROWTH RESTRICTION 32
584 HAEMOLYTIC ANAEMIA 32
585 HYPERSOMNIA 32
586 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 32
587 INCONTINENCE 32
588 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32
589 PROTEINURIA 32
590 RENAL CYST 32
591 SKIN DISCOLOURATION 32
592 ADENOMA BENIGN 31
593 ATRIOVENTRICULAR BLOCK COMPLETE 31
594 BONE MARROW FAILURE 31
595 BUNDLE BRANCH BLOCK RIGHT 31
596 EATING DISORDER 31
597 FACE OEDEMA 31
598 GAIT INABILITY 31
599 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 31
600 MANIA 31
601 PRODUCT PRESCRIBING ISSUE 31
602 PRODUCT SUBSTITUTION ISSUE 31
603 SALIVARY HYPERSECRETION 31
604 THERAPY PARTIAL RESPONDER 31
605 ACIDOSIS HYPERCHLORAEMIC 30
606 AREFLEXIA 30
607 BRONCHITIS 30
608 CAESAREAN SECTION 30
609 DIPLOPIA 30
610 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 30
611 DRUG LEVEL ABOVE THERAPEUTIC 30
612 DYSCHEZIA 30
613 HYPERTENSIVE CRISIS 30
614 ILEUS PARALYTIC 30
615 ISCHAEMIA 30
616 LARYNGEAL OEDEMA 30
617 MALNUTRITION 30
618 MOTOR DYSFUNCTION 30
619 NEUTROPENIC SEPSIS 30
620 PRODUCT PREPARATION ISSUE 30
621 PULMONARY ARTERIAL HYPERTENSION 30
622 RHINORRHOEA 30
623 SEIZURE LIKE PHENOMENA 30
624 SKIN EXFOLIATION 30
625 THROMBOSIS 30
626 TRISMUS 30
627 APHTHOUS ULCER 29
628 APPENDICITIS 29
629 DELUSION 29
630 FOURNIER^S GANGRENE 29
631 HAEMORRHAGE INTRACRANIAL 29
632 HEPATIC ISCHAEMIA 29
633 HEPATITIS CHOLESTATIC 29
634 HEPATITIS FULMINANT 29
635 LARGE INTESTINE POLYP 29
636 LUNG INFECTION 29
637 MYOGLOBIN URINE PRESENT 29
638 NASAL CONGESTION 29
639 PARKINSON^S DISEASE 29
640 PERITONITIS 29
641 POLYNEUROPATHY 29
642 ABDOMINAL RIGIDITY 28
643 ANGER 28
644 BLOOD POTASSIUM DECREASED 28
645 CARDIOMYOPATHY 28
646 CARDIOPULMONARY FAILURE 28
647 CYTOMEGALOVIRUS INFECTION 28
648 DISABILITY 28
649 HEPATORENAL SYNDROME 28
650 INTRA-ABDOMINAL HAEMORRHAGE 28
651 LYMPHOCYTE COUNT DECREASED 28
652 MALABSORPTION 28
653 OSTEOPOROSIS 28
654 ROAD TRAFFIC ACCIDENT 28
655 SINUS ARREST 28
656 SUDDEN DEATH 28
657 TRANSIENT ISCHAEMIC ATTACK 28
658 AKATHISIA 27
659 BLOOD ALBUMIN DECREASED 27
660 BLOOD GASES ABNORMAL 27
661 BONE DENSITY DECREASED 27
662 CHOLELITHIASIS 27
663 DERMATITIS EXFOLIATIVE GENERALISED 27
664 ECZEMA 27
665 EUPHORIC MOOD 27
666 EYE MOVEMENT DISORDER 27
667 FOETAL DEATH 27
668 GENERALISED OEDEMA 27
669 GRAFT VERSUS HOST DISEASE 27
670 HAEMATOCRIT DECREASED 27
671 HERPES ZOSTER 27
672 INTESTINAL OBSTRUCTION 27
673 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27
674 MOUTH HAEMORRHAGE 27
675 MYOCARDIAL DEPRESSION 27
676 PLEOCYTOSIS 27
677 REFUSAL OF TREATMENT BY PATIENT 27
678 RESPIRATION ABNORMAL 27
679 THINKING ABNORMAL 27
680 TRIGEMINO-CARDIAC REFLEX 27
681 VAGAL NERVE STIMULATOR IMPLANTATION 27
682 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 26
683 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 26
684 APLASTIC ANAEMIA 26
685 CARDIOVASCULAR DISORDER 26
686 DRY EYE 26
687 EXTRASYSTOLES 26
688 HYPERKINESIA 26
689 HYPOAESTHESIA ORAL 26
690 INSURANCE ISSUE 26
691 INTRA-ABDOMINAL PRESSURE INCREASED 26
692 MATERNAL EXPOSURE DURING DELIVERY 26
693 NEGATIVE PRESSURE PULMONARY OEDEMA 26
694 RASH MACULAR 26
695 RENAL NEOPLASM 26
696 SENSORY LOSS 26
697 THROMBOPHLEBITIS 26
698 AMMONIA INCREASED 25
699 ANTINUCLEAR ANTIBODY POSITIVE 25
700 ARTHRITIS 25
701 BLOOD PH DECREASED 25
702 CATHETER SITE HAEMORRHAGE 25
703 DRUG TOLERANCE 25
704 DYSGEUSIA 25
705 ERYSIPELAS 25
706 FAECAL CALPROTECTIN INCREASED 25
707 FOCAL DYSCOGNITIVE SEIZURES 25
708 GLOMERULAR FILTRATION RATE DECREASED 25
709 HEPATIC ENCEPHALOPATHY 25
710 METASTASES TO BONE 25
711 PNEUMOMEDIASTINUM 25
712 PUPIL FIXED 25
713 QUADRIPLEGIA 25
714 RENAL DISORDER 25
715 SLEEP APNOEA SYNDROME 25
716 BASAL CELL CARCINOMA 24
717 BLOOD PRESSURE SYSTOLIC INCREASED 24
718 CARDIAC FAILURE ACUTE 24
719 CHANGE IN SEIZURE PRESENTATION 24
720 CLONIC CONVULSION 24
721 CSF OLIGOCLONAL BAND PRESENT 24
722 DECUBITUS ULCER 24
723 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24
724 ECONOMIC PROBLEM 24
725 GASTRIC ULCER 24
726 HEPATIC STEATOSIS 24
727 HYPERTROPHIC CARDIOMYOPATHY 24
728 INABILITY TO AFFORD MEDICATION 24
729 INCREASED BRONCHIAL SECRETION 24
730 MOOD ALTERED 24
731 OXYGEN THERAPY 24
732 PNEUMATOSIS 24
733 RETCHING 24
734 SMALL INTESTINAL OBSTRUCTION 24
735 ANAL ABSCESS 23
736 AORTIC VALVE INCOMPETENCE 23
737 ARTERIOSCLEROSIS 23
738 BLOOD PRESSURE ABNORMAL 23
739 COMA SCALE ABNORMAL 23
740 CONJUNCTIVITIS 23
741 DEFAECATION URGENCY 23
742 DISTRIBUTIVE SHOCK 23
743 DUODENAL ULCER 23
744 DYSPNOEA EXERTIONAL 23
745 EMBOLISM 23
746 EYELID OEDEMA 23
747 FANCONI SYNDROME 23
748 FEEDING DISORDER 23
749 FLUID OVERLOAD 23
750 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 23
751 NECROTISING FASCIITIS 23
752 NO THERAPEUTIC RESPONSE 23
753 ORTHOSTATIC HYPOTENSION 23
754 POLLAKIURIA 23
755 POTENTIATING DRUG INTERACTION 23
756 PROCTALGIA 23
757 PRODUCT ADMINISTRATION ERROR 23
758 PUPILS UNEQUAL 23
759 QUADRIPARESIS 23
760 RHINOVIRUS INFECTION 23
761 SENSORY DISTURBANCE 23
762 SPINAL OSTEOARTHRITIS 23
763 THROMBOCYTOSIS 23
764 TRANSPLANT REJECTION 23
765 VOCAL CORD DYSFUNCTION 23
766 ABORTION INDUCED 22
767 BEZOAR 22
768 BRONCHOPULMONARY ASPERGILLOSIS 22
769 BURNING SENSATION 22
770 CELL DEATH 22
771 CEREBRAL ISCHAEMIA 22
772 ESCHERICHIA INFECTION 22
773 ESCHERICHIA URINARY TRACT INFECTION 22
774 EYE PAIN 22
775 FEBRILE BONE MARROW APLASIA 22
776 FUNCTIONAL GASTROINTESTINAL DISORDER 22
777 HEPATIC CIRRHOSIS 22
778 HYPERPARATHYROIDISM SECONDARY 22
779 HYPOVOLAEMIC SHOCK 22
780 IRON DEFICIENCY ANAEMIA 22
781 MUSCLE TIGHTNESS 22
782 MYOPATHY 22
783 NEPHROGENIC DIABETES INSIPIDUS 22
784 NEPHROPATHY 22
785 NEUROLOGICAL DECOMPENSATION 22
786 PERIORBITAL OEDEMA 22
787 RASH MORBILLIFORM 22
788 SECRETION DISCHARGE 22
789 STARING 22
790 SUBCUTANEOUS EMPHYSEMA 22
791 TUMOUR LYSIS SYNDROME 22
792 ABDOMINAL COMPARTMENT SYNDROME 21
793 AIRWAY COMPLICATION OF ANAESTHESIA 21
794 BRAIN HYPOXIA 21
795 CANDIDA INFECTION 21
796 CERUMEN IMPACTION 21
797 CORONARY ARTERY STENOSIS 21
798 DIABETIC KETOACIDOSIS 21
799 DRUG ADMINISTRATION ERROR 21
800 HEPARIN-INDUCED THROMBOCYTOPENIA 21
801 HYPERPYREXIA 21
802 HYPERTHYROIDISM 21
803 IMPAIRED GASTRIC EMPTYING 21
804 IMPAIRED HEALING 21
805 ISCHAEMIC HEPATITIS 21
806 LACRIMATION INCREASED 21
807 LANGUAGE DISORDER 21
808 METASTASES TO LIVER 21
809 NECROSIS 21
810 NEOPLASM MALIGNANT 21
811 NEPHROPATHY TOXIC 21
812 PARAPLEGIA 21
813 PCO2 INCREASED 21
814 PROCEDURAL VOMITING 21
815 PULMONARY MASS 21
816 TERMINAL STATE 21
817 VARICOSE VEIN 21
818 VERTIGO 21
819 VULVOVAGINAL CANDIDIASIS 21
820 ACCIDENTAL EXPOSURE TO PRODUCT 20
821 AIRWAY PEAK PRESSURE INCREASED 20
822 ANAL FISSURE 20
823 ANGINA PECTORIS 20
824 ATONIC SEIZURES 20
825 BLOOD BICARBONATE DECREASED 20
826 BRADYCARDIA FOETAL 20
827 BREATH SOUNDS ABNORMAL 20
828 BUNDLE BRANCH BLOCK LEFT 20
829 BURKHOLDERIA TEST POSITIVE 20
830 CHOLECYSTITIS ACUTE 20
831 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 20
832 DERMATOSIS 20
833 ERYTHEMA MULTIFORME 20
834 EXTRA DOSE ADMINISTERED 20
835 EXTREMITY NECROSIS 20
836 FIBROMA 20
837 HYDROCEPHALUS 20
838 HYDRONEPHROSIS 20
839 HYPOPHOSPHATAEMIA 20
840 HYPORESPONSIVE TO STIMULI 20
841 IMMUNOSUPPRESSION 20
842 INFLUENZA LIKE ILLNESS 20
843 MELANOCYTIC NAEVUS 20
844 MOUTH ULCERATION 20
845 MUSCLE SPASTICITY 20
846 MYOGLOBIN BLOOD INCREASED 20
847 NERVOUSNESS 20
848 NEUROMUSCULAR BLOCKADE 20
849 ORGAN FAILURE 20
850 PAIN IN JAW 20
851 PARKINSONISM 20
852 PATHOLOGICAL FRACTURE 20
853 PLATELET COUNT INCREASED 20
854 PYELONEPHRITIS 20
855 RED BLOOD CELL COUNT DECREASED 20
856 SCHIZOPHRENIA 20
857 SKIN ULCER 20
858 THERAPEUTIC RESPONSE UNEXPECTED 20
859 TYPE I HYPERSENSITIVITY 20
860 ADRENAL INSUFFICIENCY 19
861 ANAL PROLAPSE 19
862 ANTICONVULSANT DRUG LEVEL INCREASED 19
863 BRAIN FOG 19
864 DEVICE MALFUNCTION 19
865 DEVICE RELATED SEPSIS 19
866 DRUG CLEARANCE DECREASED 19
867 EAR INFECTION 19
868 EOSINOPHIL COUNT INCREASED 19
869 FAECES DISCOLOURED 19
870 FEMUR FRACTURE 19
871 HAEMODIALYSIS 19
872 HICCUPS 19
873 HYPERLACTACIDAEMIA 19
874 HYPERLIPIDAEMIA 19
875 HYPOPNOEA 19
876 ILL-DEFINED DISORDER 19
877 INJECTION SITE ERYTHEMA 19
878 ISCHAEMIC STROKE 19
879 MUSCULOSKELETAL PAIN 19
880 NECROTISING COLITIS 19
881 NEONATAL RESPIRATORY DEPRESSION 19
882 NORMAL NEWBORN 19
883 ON AND OFF PHENOMENON 19
884 OSTEOMYELITIS 19
885 OSTEONECROSIS OF JAW 19
886 PNEUMONIA STAPHYLOCOCCAL 19
887 POSTOPERATIVE DELIRIUM 19
888 PRODUCT PRESCRIBING ERROR 19
889 PSEUDOMONAL SEPSIS 19
890 PUSTULE 19
891 RENAL CELL CARCINOMA 19
892 SKIN LACERATION 19
893 SUBDURAL HAEMORRHAGE 19
894 SURGERY 19
895 SYMPTOM MASKED 19
896 TENDON RUPTURE 19
897 THERAPY CESSATION 19
898 THIRST 19
899 VENTRICULAR DYSFUNCTION 19
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 19
901 ABNORMAL FAECES 18
902 ABSCESS LIMB 18
903 AFFECTIVE DISORDER 18
904 BLOOD PRESSURE SYSTOLIC DECREASED 18
905 BONE PAIN 18
906 CHEST WALL RIGIDITY 18
907 CHOLECYSTITIS 18
908 CONCOMITANT DISEASE AGGRAVATED 18
909 DELAYED GRAFT FUNCTION 18
910 EAR PAIN 18
911 ENDOTRACHEAL INTUBATION COMPLICATION 18
912 GASTROINTESTINAL INFLAMMATION 18
913 HYPERPHOSPHATAEMIA 18
914 HYPERVOLAEMIA 18
915 ILLUSION 18
916 INFLAMMATORY MARKER INCREASED 18
917 LABORATORY TEST ABNORMAL 18
918 MACROGLOSSIA 18
919 MECHANICAL VENTILATION 18
920 ODYNOPHAGIA 18
921 PO2 INCREASED 18
922 PRESYNCOPE 18
923 PRODUCT CONTAMINATION 18
924 RALES 18
925 RENAL ISCHAEMIA 18
926 SKIN LESION 18
927 SUPERINFECTION 18
928 TACHYPHYLAXIS 18
929 TROPONIN I INCREASED 18
930 WHITE MATTER LESION 18
931 WOUND 18
932 WRONG DRUG ADMINISTERED 18
933 APALLIC SYNDROME 17
934 APPENDICITIS PERFORATED 17
935 AXILLARY PAIN 17
936 BLINDNESS 17
937 BLOOD GLUCOSE ABNORMAL 17
938 BLOOD PRESSURE FLUCTUATION 17
939 BLOOD PROLACTIN INCREASED 17
940 BREAST CANCER METASTATIC 17
941 CARBOHYDRATE ANTIGEN 125 INCREASED 17
942 CARCINOID CRISIS 17
943 CARDIAC DYSFUNCTION 17
944 COMPLEX PARTIAL SEIZURES 17
945 DEMENTIA ALZHEIMER^S TYPE 17
946 DERMATITIS ALLERGIC 17
947 DROOLING 17
948 EYE SWELLING 17
949 FEELING COLD 17
950 GENERAL PHYSICAL CONDITION ABNORMAL 17
951 GENERALISED ERYTHEMA 17
952 HIATUS HERNIA 17
953 INGUINAL HERNIA 17
954 INTERVERTEBRAL DISC DEGENERATION 17
955 LIVE BIRTH 17
956 MONOCYTE COUNT INCREASED 17
957 MUCOSAL ULCERATION 17
958 MYELOSUPPRESSION 17
959 NEOPLASM PROGRESSION 17
960 NEURALGIA 17
961 NIGHTMARE 17
962 OEDEMA MUCOSAL 17
963 ORAL HERPES 17
964 PUPILLARY REFLEX IMPAIRED 17
965 RESPIRATORY ALKALOSIS 17
966 SCAR 17
967 SCREAMING 17
968 SKIN DISORDER 17
969 STAPHYLOCOCCAL BACTERAEMIA 17
970 TARDIVE DYSKINESIA 17
971 ABDOMINAL PAIN LOWER 16
972 ACUTE LUNG INJURY 16
973 ACUTE POSTOPERATIVE SIALADENITIS 16
974 ANGLE CLOSURE GLAUCOMA 16
975 ATRIOVENTRICULAR BLOCK FIRST DEGREE 16
976 BACTERIAL INFECTION 16
977 BLOOD TRIGLYCERIDES INCREASED 16
978 BRAIN NATRIURETIC PEPTIDE INCREASED 16
979 BRAIN NEOPLASM 16
980 BULIMIA NERVOSA 16
981 CHOKING 16
982 COMPARTMENT SYNDROME 16
983 DRUG EFFECT LESS THAN EXPECTED 16
984 DRUG SCREEN POSITIVE 16
985 ELECTROCARDIOGRAM T WAVE ABNORMAL 16
986 ELECTROCARDIOGRAM T WAVE INVERSION 16
987 ENTEROBACTER INFECTION 16
988 EXPIRED PRODUCT ADMINISTERED 16
989 FEELING OF DESPAIR 16
990 GAZE PALSY 16
991 HEPATOMEGALY 16
992 HIP FRACTURE 16
993 HYPOTONIA NEONATAL 16
994 IMPAIRED QUALITY OF LIFE 16
995 INCORRECT DRUG ADMINISTRATION RATE 16
996 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 16
997 LARGE INTESTINE PERFORATION 16
998 LARYNGEAL STENOSIS 16
999 LIPASE INCREASED 16